Abrocitinib: A Comprehensive Review of its Efficacy and Safety in Dermatology

• Main Authors: Sunil Dogra (Author), Shikha Shah (Author), Manavi Gupta (Author), Ayush Sharma (Author), Seema Chhabra (Author)
• Format: Book
• Published: Wolters Kluwer Medknow Publications, 2024-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abrocitinib is a novel oral small molecule which acts as a selective JAK-1 inhibitor. Currently approved for use in moderate-to-severe cases of atopic dermatitis, this drug is gaining a rapid impetus for its use across various inflammatory dermatoses for its selective downstream action on cytokines...